Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)
Dermatol Ther (Heidelb). 2024 May 2. doi: 10.1007/s13555-024-01157-5. Online ahead of print. ABSTRACT INTRODUCTION: Atopic dermatitis (AD) is characterized by intense itch and other symptoms …